Skip to main content

Table 2 Mean utility values in England and Scotland.

From: Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

 

England (N = 59)

Scotland (N = 30)

 

Health State

Mean ± SD

Mean ± SD

Difference ( p )

Complete Response

0.90 ± 0.12

0.92 ± 0.08

0.39

Partial Response

0.83 ± 0.16

0.87 ± 0.09

0.18

No Change

0.76 ± 0.15

0.83 ± 0.11

0.02

Progressive Disease

0.64 ± 0.21

0.75 ± 0.17

0.01

NC + 1-2 Nausea

0.70 ± 0.17

0.78 ± 0.16

0.04

NC + 1-2 Nausea/Vomiting

0.70 ± 0.16

0.78 ± 0.15

0.03

NC + 1-2 Diarrhea

0.68 ± 0.19

0.75 ± 0.17

0.07

NC + 3-4 Anemia

0.66 ± 0.19

0.74 ± 0.17

0.04

NC + 3-4 Pyrexia

0.64 ± 0.17

0.72 ± 0.17

0.03

NC + 3-4 Pneumonia

0.56 ± 0.20

0.63 ± 0.19

0.12

Second-line Treatment

0.68 ± 0.18

0.76 ± 0.13

0.02

Third-line Treatment

0.61 ± 0.24

0.72 ± 0.16

0.01

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us